Tier 2 — strong

The acute effect of Quercetin on muscle performance following a single resistance training session

Federica Patrizio, Massimiliano Ditroilo, Francesco Felici, Guglielmo Duranti, Giuseppe De Vito, Stefania Sabatini, Massimo Sacchetti, Ilenia Bazzucchi
European journal of applied physiology 2018 118(5):1021

Bibliography

PubMed
PMID 29511920
DOI
10.1007/s00421-018-3834-y
Funding
Funding was not specified in the indexed record or the disclosure metadata available for this entry.
Competing interests
A competing-interest declaration was not available in the indexed record or the disclosure metadata used for this entry.

Study snapshot

DesignRandomized double-blind acute crossover exercise study
ModelHuman intervention research
Sample10 young men
InterventionQuercetin 1,000 mg or placebo 3 hours before resistance exercise
DurationSingle-dose exercise sessions
EndpointsSource-specific outcomes described in the key findings

What the study showed, in plain terms

Published in 2018, this source examined exercise and recovery. Design: Randomized double-blind acute crossover exercise study. Sample/model: 10 young men. The exposure or intervention was Quercetin 1,000 mg or placebo 3 hours before resistance exercise. Follow-up or treatment period: Single-dose exercise sessions.

Some strength, torque-development and exercise-volume measures favored quercetin. Blood damage markers did not differ.

Very small acute male cohort. Findings do not establish sustained training adaptation.

Continue with Quercetin Data Center

For topic-level interpretation, read Quercetin for Exercise: Performance, Recovery and Muscle. This is a related guide; the citation panel separately identifies articles that directly cite this paper.

Key findings

  • Some strength, torque-development and exercise-volume measures favored quercetin.
  • Blood damage markers did not differ.
  • The recorded outcome domains were Source-specific outcomes described in the key findings.
  • The result applies to the tested exposure: Quercetin 1,000 mg or placebo 3 hours before resistance exercise; Single-dose exercise sessions.

What this study can and cannot tell us

  • Very small acute male cohort. Findings do not establish sustained training adaptation.
  • An individual controlled trial must be interpreted alongside its comparator, sample size, endpoint selection and independent replication. It does not validate a different commercial formulation or a general longevity claim.
  • Source basis: Source check: PubMed abstract and indexed metadata; full methods were not independently confirmed for this entry. Missing method details, funding information or participant denominators are not inferred.

Related papers in the corpus

Tier 2
Quercetin prophylaxis in prevention of acute mountain sickness (AMS): a randomized, double blind, placebo controlled phase-II clinical trials
Sarada S K Sagi et al. · European journal of nutrition · 2026
Tier 2
Effects of Quercetin and Citrulline on Nitric Oxide Metabolites and Antioxidant Biomarkers in Trained Cyclists
Jennifer A Kurtz et al. · Nutrients · 2025
Tier 2
Quercetin ingestion alters motor unit behavior and enhances improvement in muscle strength following resistance training in older adults: a randomized, double-blind, controlled trial
Taichi Nishikawa et al. · European journal of nutrition · 2025

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology